Jonathan Krinsky, BTIG chief market technician, joins 'Closing Bell' to discuss why he's cautious on Apple and the market ...

BTIG says a “considerable amount of our time is spent thinking and talking about” Fannie Mae (FNMA) and Freddie Mac (FMCC) because those ...

History suggests investors should be “cautious” on Apple’s stock heading into January following its recent streak of weekly gains.

Lennar (LEN – Research Report) received a Hold rating and price target from BTIG analyst Carl Reichardt yesterday. The company’s shares ...

On Friday, Cerus Corp (CERS) stock saw a decline, ending the day at $1.56 which represents a decrease of $-0.10 or -6.02% from the prior close of $1.66. The stock opened at $1.65 and touched a low of ...

It isn’t all bad news, said John Krinsky, chief market technician at BTIG, in a Wednesday client note. Tech’s XLK 1.5% fall makes it by far the worst-performing S&P 500 sector and is a concern ...

BTIG said it would be cautious on Apple's (NASDAQ:AAPL) stock heading into January 2025. Analyst Jonathan Krinsky said the market can continue to make upside progress into the year-end and see a ...

Investors should start looking at restaurant names that have timely setups, said Jonathan Krinsky, chief market technician at BTIG, in a note. “Brinker International (EAT) is not in the S&P 500 ...

BTIG raised the firm’s price target on Darden (DRI) to $205 from $195 and keeps a Buy rating on the shares after its Q2 ...

BTIG analyst Jeet Mukherjee initiated coverage of Arvinas (ARVN) with a Buy rating and $69 price target The company’s lead program, vepdegestrant, is a potent ER degrader for being developed for ...

NEW YORK--(BUSINESS WIRE)--BTIG announced today that its Digital Health Forum will take place on Monday, November 25, 2024. The event will be hosted by David Larsen, CFA, BTIG Healthcare IT and ...

https://www.tipranks.com/news/the-fly/moderna-price-target-lowered-to-45-from-59-at-jpmorgan BTIG upgraded Aclaris Therapeutics (ACRS) to Buy from Neutral with an $8 ...